Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 52 studies | 52% ± 18% | |
fibroblast | 51 studies | 78% ± 17% | |
pericyte | 42 studies | 91% ± 13% | |
smooth muscle cell | 35 studies | 89% ± 15% | |
endothelial cell of lymphatic vessel | 29 studies | 67% ± 18% | |
connective tissue cell | 20 studies | 73% ± 24% | |
mesothelial cell | 18 studies | 74% ± 18% | |
capillary endothelial cell | 17 studies | 47% ± 11% | |
oligodendrocyte | 16 studies | 37% ± 15% | |
myofibroblast cell | 16 studies | 91% ± 8% | |
astrocyte | 16 studies | 33% ± 13% | |
endothelial cell of artery | 16 studies | 56% ± 17% | |
vein endothelial cell | 15 studies | 47% ± 16% | |
endothelial cell of vascular tree | 15 studies | 43% ± 20% | |
basal cell | 15 studies | 40% ± 18% | |
oligodendrocyte precursor cell | 14 studies | 36% ± 15% | |
adipocyte | 10 studies | 43% ± 21% | |
GABAergic neuron | 8 studies | 37% ± 17% | |
neuron | 8 studies | 40% ± 20% | |
epithelial cell of proximal tubule | 7 studies | 34% ± 13% | |
abnormal cell | 7 studies | 52% ± 25% | |
glutamatergic neuron | 7 studies | 39% ± 20% | |
epithelial cell | 7 studies | 48% ± 28% | |
interneuron | 6 studies | 39% ± 18% | |
cardiac muscle cell | 6 studies | 72% ± 16% | |
Mueller cell | 6 studies | 38% ± 9% | |
melanocyte | 6 studies | 50% ± 18% | |
glial cell | 5 studies | 44% ± 19% | |
platelet | 5 studies | 27% ± 10% | |
Schwann cell | 5 studies | 52% ± 21% | |
adventitial cell | 5 studies | 78% ± 8% | |
myoepithelial cell | 5 studies | 88% ± 7% | |
hepatocyte | 5 studies | 78% ± 15% | |
glomerular endothelial cell | 4 studies | 42% ± 8% | |
podocyte | 4 studies | 50% ± 12% | |
progenitor cell | 4 studies | 52% ± 23% | |
retinal bipolar neuron | 4 studies | 35% ± 7% | |
granule cell | 4 studies | 26% ± 8% | |
luminal cell of prostate epithelium | 4 studies | 41% ± 6% | |
secretory cell | 4 studies | 37% ± 16% | |
hepatic stellate cell | 3 studies | 86% ± 5% | |
neural crest cell | 3 studies | 59% ± 6% | |
amacrine cell | 3 studies | 27% ± 8% | |
macrophage | 3 studies | 28% ± 16% | |
microglial cell | 3 studies | 49% ± 17% | |
retinal ganglion cell | 3 studies | 30% ± 9% | |
extravillous trophoblast | 3 studies | 93% ± 3% | |
placental villous trophoblast | 3 studies | 49% ± 23% | |
ciliated cell | 3 studies | 29% ± 14% | |
lymphocyte | 3 studies | 53% ± 19% | |
rod bipolar cell | 3 studies | 41% ± 6% | |
cholangiocyte | 3 studies | 56% ± 12% | |
endothelial cell of sinusoid | 3 studies | 37% ± 10% | |
muscle cell | 3 studies | 91% ± 3% | |
pancreatic ductal cell | 3 studies | 51% ± 7% | |
neural progenitor cell | 3 studies | 38% ± 13% | |
megakaryocyte | 3 studies | 37% ± 11% | |
chondrocyte | 3 studies | 49% ± 11% | |
progenitor cell of mammary luminal epithelium | 3 studies | 33% ± 8% | |
parietal epithelial cell | 3 studies | 29% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 32% ± 15% | |
lung | 11 studies | 32% ± 20% | |
kidney | 7 studies | 28% ± 13% | |
heart | 7 studies | 51% ± 17% | |
eye | 6 studies | 29% ± 12% | |
intestine | 5 studies | 57% ± 10% | |
uterus | 5 studies | 46% ± 16% | |
prostate | 5 studies | 34% ± 8% | |
skin | 5 studies | 26% ± 13% | |
breast | 5 studies | 36% ± 12% | |
adipose | 4 studies | 48% ± 28% | |
pancreas | 3 studies | 20% ± 6% | |
placenta | 3 studies | 58% ± 19% | |
liver | 3 studies | 49% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 98% | 34520.88 | 450 / 459 | 97% | 112.61 | 1087 / 1118 |
prostate | 96% | 67486.20 | 234 / 245 | 99% | 200.63 | 499 / 502 |
ovary | 100% | 58162.26 | 180 / 180 | 91% | 65.91 | 390 / 430 |
lung | 92% | 29992.14 | 529 / 578 | 94% | 95.52 | 1081 / 1155 |
thymus | 90% | 24049.61 | 585 / 653 | 93% | 83.15 | 562 / 605 |
esophagus | 83% | 130933.05 | 1203 / 1445 | 97% | 138.81 | 177 / 183 |
bladder | 100% | 102575.90 | 21 / 21 | 80% | 67.98 | 402 / 504 |
uterus | 98% | 88354.61 | 167 / 170 | 80% | 88.43 | 367 / 459 |
intestine | 86% | 113530.70 | 829 / 966 | 83% | 78.74 | 436 / 527 |
skin | 54% | 21215.85 | 978 / 1809 | 94% | 85.74 | 444 / 472 |
kidney | 53% | 14000.09 | 47 / 89 | 92% | 138.72 | 826 / 901 |
stomach | 55% | 55583.28 | 199 / 359 | 89% | 129.60 | 254 / 286 |
adrenal gland | 54% | 12151.03 | 139 / 258 | 83% | 46.65 | 190 / 230 |
liver | 29% | 5444.01 | 65 / 226 | 98% | 73.38 | 397 / 406 |
blood vessel | 100% | 162548.89 | 1335 / 1335 | 0% | 0 | 0 / 0 |
adipose | 98% | 42829.89 | 1184 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 1% | 280.98 | 4 / 328 | 96% | 145.58 | 171 / 178 |
brain | 1% | 237.42 | 28 / 2642 | 91% | 58.67 | 642 / 705 |
spleen | 76% | 22629.07 | 183 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 69% | 41.64 | 31 / 45 |
eye | 0% | 0 | 0 / 0 | 64% | 25.89 | 51 / 80 |
heart | 59% | 14708.95 | 512 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 31% | 9.09 | 9 / 29 |
muscle | 3% | 662.84 | 25 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051017 | Biological process | actin filament bundle assembly |
GO_0001525 | Biological process | angiogenesis |
GO_0006936 | Biological process | muscle contraction |
GO_0001725 | Cellular component | stress fiber |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0030016 | Cellular component | myofibril |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0030478 | Cellular component | actin cap |
GO_0045296 | Molecular function | cadherin binding |
GO_0017022 | Molecular function | myosin binding |
GO_0005523 | Molecular function | tropomyosin binding |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
Gene name | CALD1 |
Protein name | Caldesmon 1 Caldesmon (CDM) Caldesmon 1, isoform CRA_b (NAG22 protein) CALD1 protein Caldesmon 1, isoform CRA_i (Testis secretory sperm-binding protein Li 227n) |
Synonyms | CDM hCG_17453 CAD |
Description | FUNCTION: Actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also plays an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). . |
Accessions | ENST00000430085.5 ENST00000445569.6 ENST00000424922.5 [Q05682-5] ENST00000495522.1 C9J813 ENST00000436461.6 A0A6Q8PGI1 ENST00000361675.7 [Q05682-1] Q9NYG1 Q05DR4 ENST00000417172.5 [Q05682-4] ENST00000361901.6 [Q05682-4] ENST00000454108.5 ENST00000422748.5 [Q05682-6] E7EX44 E9PGZ1 Q6P707 C9JE79 Q05682 F8WE61 C9JEK3 ENST00000393118.7 [Q05682-3] ENST00000466704.1 ENST00000443197.5 ENST00000435928.1 A0A140VKA0 Q6PJM5 |